House passes measure giving terminally ill patients more access to experimental drugs

Amy Scott May 23, 2018
HTML EMBED:
COPY

House passes measure giving terminally ill patients more access to experimental drugs

Amy Scott May 23, 2018
HTML EMBED:
COPY

More patients who are terminally ill will potentially have access to experimental drugs under a measure passed by the House last night. President Donald Trump is expected to sign the so-called “right-to-try” bill. Forty states have already passed similar legislation. Currently, terminal patients not covered by those laws have only two options for getting unapproved drugs: They can enroll in clinical trials if they’re eligible or apply for experimental treatment through the FDA’s “expanded access” program. Proponents of the measure say the additional choice gives hope to patients who have exhausted other options. But the new law wouldn’t necessarily guarantee access.

Click the audio player above to hear the full story. 

We’re here to help you navigate this changed world and economy.

Our mission at Marketplace is to raise the economic intelligence of the country. It’s a tough task, but it’s never been more important.

In the past year, we’ve seen record unemployment, stimulus bills, and reddit users influencing the stock market. Marketplace helps you understand it all, will fact-based, approachable, and unbiased reporting.

Generous support from listeners and readers is what powers our nonprofit news—and your donation today will help provide this essential service. For just $5/month, you can sustain independent journalism that keeps you and thousands of others informed.